Launch week offerEnds in00h00m00s

annual Promonthly Pro

Jitka Malcikova

assistant professor

Masaryk University

Czech Republic

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Cell Biology

Articles (7)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Boris Tichy

assistant professor

Masaryk University

CZECH REPUBLIC

View details

Sarka Pavlova

assistant professor

Masaryk University

CZECH REPUBLIC

View details

Sarka Pospisilova

Masaryk University

CZECH REPUBLIC

View details

Lenka Radova

Masaryk University

CZECH REPUBLIC

View details

Monika Pepek

Rzeszów University

POLAND

View details

Terezia Kurucova

Central European Institute of Technology – Masaryk University

CZECH REPUBLIC

View details

Kamila Reblova

senior researcher

Masaryk University

CZECH REPUBLIC

View details

Panagiotis Baliakas

Uppsala University

SWEDEN

View details

Jana Kotaskova

Senior researcher

Masaryk University

CZECH REPUBLIC

View details

M ROCIO BENITO SANCHEZ

Professor

Universidad de Salamanca

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jitka Malcikova

Research Interests

Make your next move.

Explore related searches

Articles (7)

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL

Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update

Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment‐naïve CLL patients

Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?

Jak klinicky interpretovat výsledky TP53 analýz u chronické lymfocytární leukemie v kontextu dostupných terapeutických režimů

Collaborators (10)

Boris Tichy

Sarka Pavlova

Sarka Pospisilova

Lenka Radova

Monika Pepek

Terezia Kurucova

Kamila Reblova

Panagiotis Baliakas

Jana Kotaskova

M ROCIO BENITO SANCHEZ

Make your next move.